Advicenne
- Biotech or pharma, therapeutic R&D
2024 LATEST: ADVICENNE RECEIVE ODD DESIGNATION FOR ADV7103 IN CYSTINURIA, ADDING TO THE ODD ALREADY ACHIEVED IN dRTA.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}